𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma

✍ Scribed by Robert S. Witte; Traci Leong; Marc S. Ernstoff; Robert L. Krigel; Martin M. Oken; Jules Harris; Douglass C. Tormey; Donald L. Trump

Publisher
Springer US
Year
1995
Tongue
English
Weight
471 KB
Volume
13
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of recombinant beta inter
Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma
✍ Ettinger, David S. ;Harwood, Kerry πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a

A Phase II study of irinotecan in patien
A Phase II study of irinotecan in patients with advanced renal cell carcinoma
✍ Karim Fizazi; FrΓ©dΓ©ric Rolland; Christine Chevreau; Jean-Pierre Droz; Dominique πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Patients with disseminated renal cell carcinoma (RCC) have a poor outcome, and the disease is considered highly resistant to chemotherapy. Irinotecan is an active drug in the treatment of a number of neoplastic diseases and is not concerned with the multidrug‐resistance p